71 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over … of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
Critical audit
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors (with power of delegation to its audit committee … Board of Directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors in accordance with the volume
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
, and to authorize the Company’s Board of Directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors
6-K
EX-99.1
pu1tytxax9h77ra
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
74brxqys
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
rsj23n4pfyu dq7c
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
zu4fry2 ql
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
F-3
qza0tmm5a2699aj0e6fk
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.2
797o2y8
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
ih3b8
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-1.1
225mln
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm